These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
512 related articles for article (PubMed ID: 16537623)
1. Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal species. Jogler C; Hoffmann D; Theegarten D; Grunwald T; Uberla K; Wildner O J Virol; 2006 Apr; 80(7):3549-58. PubMed ID: 16537623 [TBL] [Abstract][Full Text] [Related]
2. Replication of an adenoviral vector controlled by the human telomerase reverse transcriptase promoter causes tumor-selective tumor lysis. Lanson NA; Friedlander PL; Schwarzenberger P; Kolls JK; Wang G Cancer Res; 2003 Nov; 63(22):7936-41. PubMed ID: 14633724 [TBL] [Abstract][Full Text] [Related]
3. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity. Wildner O; Morris JC Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625 [TBL] [Abstract][Full Text] [Related]
4. A novel ex vivo model system for evaluation of conditionally replicative adenoviruses therapeutic efficacy and toxicity. Kirby TO; Rivera A; Rein D; Wang M; Ulasov I; Breidenbach M; Kataram M; Contreras JL; Krumdieck C; Yamamoto M; Rots MG; Haisma HJ; Alvarez RD; Mahasreshti PJ; Curiel DT Clin Cancer Res; 2004 Dec; 10(24):8697-703. PubMed ID: 15623655 [TBL] [Abstract][Full Text] [Related]
5. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase. Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the biodistribution, persistence, toxicity, and potential of germ-line transmission of a replication-competent human adenovirus following intraprostatic administration in the mouse. Paielli DL; Wing MS; Rogulski KR; Gilbert JD; Kolozsvary A; Kim JH; Hughes J; Schnell M; Thompson T; Freytag SO Mol Ther; 2000 Mar; 1(3):263-74. PubMed ID: 10933942 [TBL] [Abstract][Full Text] [Related]
7. Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coli. Hoffmann D; Wildner O BMC Biotechnol; 2006 Aug; 6():36. PubMed ID: 16887042 [TBL] [Abstract][Full Text] [Related]
10. Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors. Thomas MA; Spencer JF; La Regina MC; Dhar D; Tollefson AE; Toth K; Wold WS Cancer Res; 2006 Feb; 66(3):1270-6. PubMed ID: 16452178 [TBL] [Abstract][Full Text] [Related]
11. Targeted expression of herpes simplex virus thymidine kinase in adenovirus-infected cells reduces virus titers upon treatment with ganciclovir in vitro. Ibrišimović M; Nagl U; Kneidinger D; Rauch M; Lion T; Klein R J Gene Med; 2012 Jan; 14(1):3-19. PubMed ID: 22190534 [TBL] [Abstract][Full Text] [Related]
12. Human adenovirus replication in immunocompetent Syrian hamsters can be attenuated with chlorpromazine or cidofovir. Diaconu I; Cerullo V; Escutenaire S; Kanerva A; Bauerschmitz GJ; Hernandez-Alcoceba R; Pesonen S; Hemminki A J Gene Med; 2010 May; 12(5):435-45. PubMed ID: 20440754 [TBL] [Abstract][Full Text] [Related]
13. Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice. Zsengeller ZK; Wert SE; Hull WM; Hu X; Yei S; Trapnell BC; Whitsett JA Hum Gene Ther; 1995 Apr; 6(4):457-67. PubMed ID: 7612702 [TBL] [Abstract][Full Text] [Related]
14. Isogenic adenoviruses type 5 expressing or not expressing the E1A gene: efficiency as virus vectors in the vaccination of permissive and non-permissive species. Eloit M; Adam M J Gen Virol; 1995 Jul; 76 ( Pt 7)():1583-9. PubMed ID: 9049365 [TBL] [Abstract][Full Text] [Related]
15. An ovine adenovirus vector lacks transforming ability in cells that are transformed by AD5 E1A/B sequences. Xu ZZ; Nevels M; MacAvoy ES; Lockett LJ; Curiel D; Dobner T; Both GW Virology; 2000 Apr; 270(1):162-72. PubMed ID: 10772988 [TBL] [Abstract][Full Text] [Related]
16. Common structure of rare replication-deficient E1-positive particles in adenoviral vector batches. Murakami P; Havenga M; Fawaz F; Vogels R; Marzio G; Pungor E; Files J; Do L; Goudsmit J; McCaman M J Virol; 2004 Jun; 78(12):6200-8. PubMed ID: 15163713 [TBL] [Abstract][Full Text] [Related]
17. Pathology in Permissive Syrian Hamsters after Infection with Species C Human Adenovirus (HAdV-C) Is the Result of Virus Replication: HAdV-C6 Replicates More and Causes More Pathology than HAdV-C5. Tollefson AE; Ying B; Spencer JF; Sagartz JE; Wold WSM; Toth K J Virol; 2017 May; 91(10):. PubMed ID: 28250128 [TBL] [Abstract][Full Text] [Related]
18. Substitution of the adenovirus serotype 5 knob with a serotype 3 knob enhances multiple steps in virus replication. Kawakami Y; Li H; Lam JT; Krasnykh V; Curiel DT; Blackwell JL Cancer Res; 2003 Mar; 63(6):1262-9. PubMed ID: 12649186 [TBL] [Abstract][Full Text] [Related]
19. Noninvasive visualization of adenovirus replication with a fluorescent reporter in the E3 region. Ono HA; Le LP; Davydova JG; Gavrikova T; Yamamoto M Cancer Res; 2005 Nov; 65(22):10154-8. PubMed ID: 16287998 [TBL] [Abstract][Full Text] [Related]
20. Concomitant use of Ad5/35 chimeric oncolytic adenovirus with TRAIL gene and taxol produces synergistic cytotoxicity in gastric cancer cells. Chen L; Chen D; Gong M; Na M; Li L; Wu H; Jiang L; Qian Y; Fang G; Xue X Cancer Lett; 2009 Nov; 284(2):141-8. PubMed ID: 19447545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]